BMO资本市场维持艾伯维公司(ABBV.US)买入评级，上调目标价至220美元

BMO Capital analyst Evan Seigerman maintains $AbbVie (ABBV.US)$ with a buy rating, and adjusts the target price from $214 to $220.

According to TipRanks data, the analyst has a success rate of 51.7% and a total average return of 8.4% over the past year.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

海量资讯、精准解读，尽在新浪财经APP